Metabolic Solutions Development

About:

Metabolic Solutions Development develops innovative therapeutics based on a novel pharmacological method to treat type two diabetes.

Website: http://www.msdrx.com

Twitter/X: msdrx

Top Investors: Alzheimer's Drug Discovery Foundation, Hopen Life Science Ventures

Description:

Metabolic Solutions Development Company is an emerging biopharmaceutical company developing first in class oral therapeutics to treat diseases associated with metabolic dysfunction, including NASH, polycystic kidney disease, and diabetes, as well as neurodegenerative diseases such as Alzheimer's and Parkinson's disease.

Total Funding Amount:

$58.5M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Kalamazoo, Michigan, United States

Founded Date:

2006-01-01

Founders:

Jerry Colca, Rolf Kletzien

Number of Employees:

11-50

Last Funding Date:

2015-09-25

IPO Status:

Private

Industries:

© 2025 bioDAO.ai